nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomized multicenter trial to evaluate early invasive strategy for patients with acute ST-segment elevation myocardial infarction presenting 24-48 hours from symptom onset: Protocol of the RESCUE-MI study
|
Gao, Wei |
|
|
251 |
C |
p. 54-60 |
artikel |
2 |
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model
|
Aulin, Julia |
|
|
251 |
C |
p. 13-24 |
artikel |
3 |
Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial
|
Wazni, Oussama M. |
|
|
251 |
C |
p. 35-42 |
artikel |
4 |
Contemporary outpatient management of patients with worsening heart failure with reduced ejection fraction: Rationale and design of the CHART-HF study
|
Greene, Stephen J. |
|
|
251 |
C |
p. 127-136 |
artikel |
5 |
Editorial Board
|
|
|
|
251 |
C |
p. iii-iv |
artikel |
6 |
Information for Readers
|
|
|
|
251 |
C |
p. v |
artikel |
7 |
Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease
|
Mazhar, Faizan |
|
|
251 |
C |
p. 78-90 |
artikel |
8 |
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial
|
Blumenthal, James A. |
|
|
251 |
C |
p. 91-100 |
artikel |
9 |
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial
|
Cantor, Warren J. |
|
|
251 |
C |
p. 1-12 |
artikel |
10 |
Predicting heart failure in atrial fibrillation patients: What about using biomarkers?
|
López-Gálvez, Raquel |
|
|
251 |
C |
p. 32-34 |
artikel |
11 |
Rationale and design of switch Swedeheart: A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome
|
Omerovic, Elmir |
|
|
251 |
C |
p. 70-77 |
artikel |
12 |
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis
|
Park, Dae Yong |
|
|
251 |
C |
p. 101-114 |
artikel |
13 |
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)
|
O'Donoghue, Michelle L. |
|
|
251 |
C |
p. 61-69 |
artikel |
14 |
Table of Contents
|
|
|
|
251 |
C |
p. i-ii |
artikel |
15 |
The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a prospective multicenter randomized trial
|
Gwag, Hye Bin |
|
|
251 |
C |
p. 25-31 |
artikel |
16 |
Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial
|
Pierce, Jacob B. |
|
|
251 |
C |
p. 115-126 |
artikel |
17 |
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study
|
Klok, Frederikus A. |
|
|
251 |
C |
p. 43-53 |
artikel |